GRHL2 and metabolic dysfunction-associated steatotic liver disease: Particularly, transcription factor GRHL2, which was up‐regulated in NAFLD patients and mouse models, could up‐regulate miR‐200 by binding to miR‐200 promoter, thereby inhibiting the expression of SIRT1.